Last reviewed · How we verify
Marinol
At a glance
| Generic name | Marinol |
|---|---|
| Also known as | Dronabinol |
| Sponsor | Jazz Pharmaceuticals |
| Target | N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1 |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Anorexia from HIV
- Chemotherapy-induced nausea and vomiting
Common side effects
- Dizziness
- Euphoria
- Paranoid reaction
- Somnolence
- Thinking abnormal
- Abdominal pain
- Nausea
- Vomiting
- High (easy laughing, elation, heightened awareness)
- CNS adverse reaction
- Palpitations
- Tachycardia
Serious adverse events
- Seizures
- Syncope
- Loss of consciousness
- Delirium
- Panic attack
- Fall
- Disorientation
- Movement disorder
- Hypersensitivity reactions (lip swelling, hives, rash, oral lesions)
- Hemodynamic instability
Key clinical trials
- EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA) (PHASE1, PHASE2)
- Dronabinol in Total Knee Arthroplasty (TKA) (PHASE4)
- AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) (PHASE1)
- Effects of Dronabinol in Opioid Maintained Patients (EARLY_PHASE1)
- Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment (PHASE2)
- Dronabinol as an Adjunct for Reducing Pain (PHASE2)
- Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital (PHASE2)
- Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Marinol CI brief — competitive landscape report
- Marinol updates RSS · CI watch RSS
- Jazz Pharmaceuticals portfolio CI